Literature DB >> 14718815

Carotid artery stenting: is there a need to revise ultrasound velocity criteria?

Brajesh K Lal1, Robert W Hobson, Jonathan Goldstein, Elie Y Chakhtoura, Walter N Durán.   

Abstract

OBJECTIVES: Ultrasound (US) velocity criteria have not been well-established for patients undergoing carotid artery stenting (CAS). A potential source of error in using US after CAS is that reduced compliance in the stented artery may result in elevated velocity relative to the native artery. We measured arterial compliance in the stented artery, and developed customized velocity criteria for use early after CAS.
METHODS: US was performed before and within 3 days after CAS, and after 1 month in a subset of 26 patients. Post-procedural peak systolic velocity (PSV) and end-diastolic velocity (EDV) of the internal carotid artery (ICA), PSV/EDV ratio, and internal carotid artery to common carotid artery ratio (ICA/CCA) were recorded. These were compared with degree of in-stent residual stenosis determined at carotid angiography performed at the completion of CAS. Peterson's elastic modulus (Ep) and compliance (Cp) of the ICA were determined in a subgroup of 20 patients at the distal end of the stent and in the same region in the native ICA before stenting.
RESULTS: Ninety CAS procedures were analyzed. Mean (+/-SD) angiographic residual stenosis after CAS was 5.4 +/- 9.1%, whereas corresponding PSV by US was 120.4 +/- 32.4 cm/s; EDV, 41.4 +/- 18.6 cm/s; PSV/EDV ratio, 3.3 +/- 1.2; and ICA/CCA ratio, 1.6 +/- 0.5. PSV was unchanged at 1 month. Post-CAS PSV and ICA/CCA ratio correlated most with degree of stenosis (P <.0001 for both). Only six patients demonstrated in-stent residual stenosis 20% or greater, but the standard US threshold of PSV 130 cm/s or greater (validated for >20% ICA stenosis in our laboratory) categorized 38 of 90 patients as having stenosis 20% or greater. Receiver operator curve analysis demonstrated that a combined threshold of PSV 150 cm/s or greater and ICA/CCA ratio 2.16 or greater were optimal for detecting residual stenosis of 20% or greater, with sensitivity 100%, specificity 98%, positive predictive value 75%, and negative predictive value 100%. After placement of a stent, the ICA demonstrated significantly increased Ep (1.2 vs 4.4 x 10(3) mm Hg; P =.004) and decreased Cp (9.8 vs 3.2 %mm Hg x 10(-2); P =.0004).
CONCLUSIONS: Currently accepted US velocity criteria validated in our laboratory for nonstented ICAs falsely classified several stented ICAs with normal diameter on carotid angiograms as having residual in-stent stenosis 20% or greater. We propose a new criterion that defines PSV less than 150 cm/s, with ICA/CCA ratio less than 2.16, as the best correlate to a normal lumen (0%-19% stenosis) in the recently stented ICA. This was associated with increased stiffness of the stented ICA (increased Ep, decreased Cp). These preliminary results suggest that placement of a stent in the carotid artery alters its biomechanical properties, which may cause an increase in US velocity measurements in the absence of a technical error or residual stenotic disease.

Entities:  

Mesh:

Year:  2004        PMID: 14718815     DOI: 10.1016/j.jvs.2003.10.043

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  22 in total

Review 1.  Carotid endarterectomy and stenting in management of extracranial carotid occlusive disease.

Authors:  Robert W Hobson
Journal:  World J Surg       Date:  2005       Impact factor: 3.352

2.  High rate of restenosis after carotid artery stenting in patients with high-grade internal carotid artery stenosis. Medium-term follow-up.

Authors:  Judith U Harrer; Ralf Morschel; Michael Mull; Christoph M Kosinski
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

3.  [Stent and surgery for symptomatic carotid stenosis. SPACE study results].

Authors:  P A Ringleb; W Hacke
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214

4.  Carotid endarterectomy versus stenting: Does the flow really change? An Echo-Color-Doppler analysis.

Authors:  Pierleone Lucatelli; Fabrizio Fanelli; Carlo Cirelli; Beatrice Sacconi; Michele Anzidei; Roberto Montisci; Roberto Sanfilippo; Elisabetta Tamponi; Carlo Catalano; Luca Saba
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-20       Impact factor: 2.357

Review 5.  Treatment of carotid artery disease: stenting or surgery.

Authors:  Brajesh K Lal; Robert W Hobson
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

6.  Agreement between site-reported and ultrasound core laboratory results for duplex ultrasound velocity measurements in the Carotid Revascularization Endarterectomy versus Stenting Trial.

Authors:  R Eugene Zierler; Kirk W Beach; Robert O Bergelin; Brajesh K Lal; Wesley S Moore; Gary S Roubin; Jenifer H Voeks; Thomas G Brott
Journal:  J Vasc Surg       Date:  2013-09-19       Impact factor: 4.268

7.  The incidence of carotid in-stent stenosis is underestimated ≥50% or ≥80% and its clinical implications.

Authors:  Ali F AbuRahma; Zachary T AbuRahma; Grant Scott; Elliot Adams; Abe Mata; Matthew Beasley; L Scott Dean; Elaine Davis
Journal:  J Vasc Surg       Date:  2018-12-11       Impact factor: 4.268

8.  Influence of the hostile neck on restenosis after carotid stenting.

Authors:  Kevin A Brown; Dina S Itum; Yazan Duwayri; James G Reeves; Ravi Rajani; Ravi K Veeraswamy; Shipra Arya; Atef Salam; Thomas F Dodson; Luke P Brewster
Journal:  Ann Vasc Surg       Date:  2014-06-12       Impact factor: 1.466

9.  Clinical effectiveness of secondary interventions for restenosis after renal artery stenting.

Authors:  Thomas A Simone; Benjamin S Brooke; Philip P Goodney; Daniel B Walsh; David H Stone; Richard J Powell; Jack L Cronenwett; Brian W Nolan
Journal:  J Vasc Surg       Date:  2013-05-18       Impact factor: 4.268

Review 10.  Optimal cut-off criteria for duplex ultrasound for the diagnosis of restenosis in stented carotid arteries: review and protocol for a diagnostic study.

Authors:  Paul J Nederkoorn; Martin M Brown
Journal:  BMC Neurol       Date:  2009-07-22       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.